Medicaid Reform Bill Is A Draw For Pharma; Pharmacy Continues Its Fight
Executive Summary
The conference report on budget reconciliation creates a new definition of the Medicaid federal upper limit for pharmacy reimbursement for multiple source drugs
You may also be interested in...
Medicaid AMPs May Include More PBM Discounts, If CMS Can Figure Out How
CMS wants to include a broader array of pharmacy benefit manager price concessions in calculating Medicaid average manufacturer prices for reimbursing outpatient prescription drugs
Medicaid AMPs May Include More PBM Discounts, If CMS Can Figure Out How
CMS wants to include a broader array of pharmacy benefit manager price concessions in calculating Medicaid average manufacturer prices for reimbursing outpatient prescription drugs
McKesson Denies Role In Setting First DataBank AWPs
McKesson did not conspire with First DataBank to set average wholesale prices and the wholesaler intends to "vigorously" defend itself against allegations in the Prescription Access Litigation Project class action suit that it deliberately reported inflated wholesale acquisition costs to FDB, according to CEO John Hammergren